Company Quick10K Filing
West Pharmaceutical Services
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 75 $9,166
10-Q 2019-10-29 Quarter: 2019-09-30
10-Q 2019-07-29 Quarter: 2019-06-30
10-Q 2019-05-08 Quarter: 2019-03-31
10-K 2019-02-28 Annual: 2018-12-31
10-Q 2018-10-30 Quarter: 2018-09-30
10-Q 2018-07-31 Quarter: 2018-06-30
10-Q 2018-05-08 Quarter: 2018-03-31
10-K 2018-02-26 Annual: 2017-12-31
10-Q 2017-10-31 Quarter: 2017-09-30
10-Q 2017-08-01 Quarter: 2017-06-30
10-Q 2017-05-05 Quarter: 2017-03-31
10-K 2017-02-28 Annual: 2016-12-31
10-Q 2016-10-31 Quarter: 2016-09-30
10-Q 2016-08-01 Quarter: 2016-06-30
10-Q 2016-05-06 Quarter: 2016-03-31
10-K 2016-02-26 Annual: 2015-12-31
10-Q 2015-11-02 Quarter: 2015-09-30
10-Q 2015-08-03 Quarter: 2015-06-30
10-Q 2015-05-06 Quarter: 2015-03-31
10-K 2015-02-25 Annual: 2014-12-31
10-Q 2014-11-03 Quarter: 2014-09-30
10-Q 2014-08-01 Quarter: 2014-06-30
10-Q 2014-05-08 Quarter: 2014-03-31
10-K 2014-02-27 Annual: 2013-12-31
10-Q 2013-11-04 Quarter: 2013-09-30
10-Q 2013-08-05 Quarter: 2013-06-30
10-Q 2013-05-06 Quarter: 2013-03-31
10-K 2013-02-27 Annual: 2012-12-31
10-Q 2012-11-05 Quarter: 2012-09-30
10-Q 2012-08-06 Quarter: 2012-06-30
10-Q 2012-05-04 Quarter: 2012-03-31
10-Q 2011-11-07 Quarter: 2011-09-30
10-Q 2011-08-05 Quarter: 2011-06-30
10-Q 2011-05-05 Quarter: 2011-03-31
10-Q 2010-11-05 Quarter: 2010-09-30
10-Q 2010-08-05 Quarter: 2010-06-30
10-Q 2010-05-06 Quarter: 2010-05-06
10-K 2010-02-25 Annual: 2009-12-31
8-K 2020-01-10 Enter Agreement, Exhibits
8-K 2019-12-10 Regulation FD, Other Events, Exhibits
8-K 2019-11-19 Officers
8-K 2019-10-24 Earnings, Regulation FD, Exhibits
8-K 2019-09-27 Officers
8-K 2019-09-04 Regulation FD, Exhibits
8-K 2019-07-25 Earnings, Regulation FD, Exhibits
8-K 2019-05-14 Regulation FD, Exhibits
8-K 2019-04-25 Earnings, Regulation FD, Exhibits
8-K 2019-03-28 Enter Agreement, Leave Agreement, Off-BS Arrangement, Exhibits
8-K 2019-02-19 Officers
8-K 2019-02-19 Regulation FD, Other Events, Exhibits
8-K 2019-02-14 Earnings, Regulation FD, Exhibits
8-K 2019-02-01 Earnings, Regulation FD
8-K 2019-01-09 Regulation FD, Exhibits
8-K 2018-10-25 Earnings, Regulation FD, Exhibits
8-K 2018-07-26 Earnings, Regulation FD, Exhibits
8-K 2018-06-21 Officers, Exhibits
8-K 2018-05-24 Regulation FD, Exhibits
8-K 2018-05-03 Regulation FD, Exhibits
8-K 2018-04-26 Earnings, Regulation FD, Exhibits
8-K 2018-03-02 Officers, Regulation FD, Exhibits
8-K 2018-02-13 Earnings, Exit Costs, Regulation FD, Other Events, Exhibits
8-K 2018-01-10 Regulation FD, Exhibits

West Pharmaceutical Services Financials

WST Metrics, Comps, Filings

Annual | Quarterly

Business

We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing and analytical lab services. Our customers include the leading biologic, generic, pharmaceutical, diagnostic, and medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes excellence in manufacturing, scientific and technical expertise and management, and enables us to partner with our customers to deliver safe, effective drug products to patients quickly and efficiently.

The Company was incorporated under the laws of the Commonwealth of Pennsylvania on July 27, 1923.

Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
West Pharmaceutical Services (WST) 9,166 32% 31.0 11% 2,123 678 1,767 574 229 292 9,042
Carlisle Companies (CSL) 8,149 27% 13.7 8% 5,397 2,814 4,645 1,276 420 713 9,741
Ashland Global Holdings (ASH) 4,925 30% 16.9 1% 7,925 4,708 2,840 838 104 428 7,230
Tilray (TLRY) 4,507 25% -40.2 -11% 1,024 664 95 24 -115 -108 4,322
Univar (UNVR) 3,689 0% 19.3 0% 7,131 5,357 8,876 0 3 347 6,715
Usana Health Sciences (USNA) 1,813 83% 9.0 20% 532 148 1,125 931 109 175 1,579
Raven Industries (RAVN) 1,244 32% 26.8 10% 377 43 389 124 38 44 1,175
Nexeo Solutions (NXEO) 757 11% 9.1 1% 2,179 1,360 4,040 452 19 169 1,533
Innophos Holdings (IPHS) 552 18% 13.4 3% 870 531 766 138 29 64 850
Hawkins (HWKN) 426 17% 8.3 6% 399 176 554 96 25 61 506
OMNOVA Solutions (OMN) 254 23% 9.0 1% 570 512 758 176 8 60 540
Foamix Pharmaceuticals (FOMX) 146 85% -1.7 -84% 76 16 2 2 -64 -63 107
MediWound (MDWD) 118 0% 35 0 0 0 0 118
Natural Alternatives International (NAII) 74 17% 4.2 7% 93 17 138 24 7 12 49
Mannatech (MTEX) 40 80% 1.3 -1% 67 40 166 132 -1 7 9
China Jo-Jo Drugstores (CJJD) 36 23% -20.8 -4% 80 57 110 26 -3 -1 21
Ocean Bio Chem (OBCI) 31 43% 7.0 8% 37 8 34 15 3 5 32
Cyanotech (CYAN) 18 40% -85.2 -7% 34 18 31 12 -2 -0 25
CTI Industries (CTIB) 12 18% -2.8 -21% 36 32 51 9 -7 -4 12
Fuwei Films (FFHL) 7 14% 4.5 -2% 455 258 304 42 -9 -9 -40

Balance Sheet ($MM)2010-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash110162230255275203236337
Accounts Receivable126175186179181200253288
Inventory147162177182181199215214
PP&E5556691,369706721778855822
Assets1,2941,5641,6721,6711,6951,7171,8631,979
Accounts Payable63103108103120122138130
Long-Term Debt358386374311225229202193
Liabilities669835765714671599583583
Stockholders' Equity
Income Statement ($MM)2010-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue1,1051,2661,3681,4211,4001,5091,5991,717
Cost of Revenue7878799349749441,0081,0861,172
Gross Profit318388435448456501513545
R&D2433383734373940
SG&A188218235229233240243263
Tax1433403733488141
Net Income658111212796144151207
Cash Flow ($MM)2010-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating138187220183212219263289
Cash Investing-74-116-150-104-130-176-134-101
Cash Financing-34-3-5-31-42-114-109-81